Skip to main content

Journals in Immunology

Elsevier's Immunology collection equips researchers with valuable insights to address the complexities of the immune system and its role in health and disease, offering original research, insightful analysis, and current theory on diagnosing, managing, and advancing treatments for allergies, asthma, and immunologic disorders.

  • Clinical Microbiology Newsletter

    • ISSN: 0196-4399
    Clinical Microbiology Newsletter is published four issues per year to provide consistent educational features and to keep pace with advances in the fast-moving field of Clinical Microbiology.Clinica... Microbiology Newsletter aims to provide articles to enable you to streamline procedures and improve results. It publishes reviews on infectious disease pathogens, reports on changes that affect your work, including articles on new diagnostic techniques, regulatory and guideline changes, and challenging diagnostic dogmas, clinical cases focused on diagnostic approaches for both common and uncommon pathogens.The journal publishes three types of articles:Mini-review... Case presentationsSnapsho... articles cover topics including:Minireview... on the epidemiology, pathogenesis, clinical presentation, diagnosis, and treatment of infectious diseases,Practical articles on common and contemporary laboratory techniques,Indispens... updates on important clinical problems that impact the clinical laboratory,Editorial... and opinions on controversial issues in laboratory medicine,Case-based articles focused on diagnostic approaches for infectious pathogens,Snapshots highlighting specific infectious pathogens, therapeutic options, and diagnostic methodologies.Helpfu... tips on improving the laboratory workplace.
  • Antiviral Research

    • ISSN: 0166-3542
    Antiviral Research aims to publish manuscripts in the field of prevention and treatment of viral diseases in humans and vertebrate animals, and encourages authors to the submit manuscripts describing the activity of well-defined chemical compounds for the treatment of viral diseases. The journal is an Official Publication of the International Society for Antiviral Research. The types of papers published in Antiviral Research includes original research reports, short communications, commentaries and invited review* articles on the control of viral infections in humans. The journal’s scope encompasses:antivira... drugs, antibodies and host-response modifiers, including their synthesis, in vitro and in vivo testing and mechanisms of action.identificatio... and validation of new drug targets;laboratory animal models of viral diseases for antiviral efficacy testing;evolution of drug-resistant viruses and the development of effective counter measures;pathogenesi... of viral diseases and mechanisms of viral evasion of host immune responses;assessment... of drug safety;new or improved vaccines against viral infections of humans; the prevention and treatment of viral diseases of vertebrate animals, and reports of the testing of veterinary vaccines in the target animal species. All papers must include a sufficiently detailed description of methods to permit other investigators to replicate the experiments. Authors reporting the antiviral effect of a novel small-molecule drug must reveal its chemical structure. Claims of in vitro or in vivo efficacy of a drug or vaccine must be supported by appropriate statistical analysis that must be clearly described in the manuscript.Antiviral Research journal does not publish reports on viral diseases of plants or of insects, crustaceans or other invertebrates. Studies of viral diseases of livestock and companion animals must be clearly related to the development of realistic therapies. Papers on veterinary vaccines should report findings in the target animal species.We discourage the submission of manuscripts reporting the antiviral activity of unpurified natural products, or of partially purified substances of natural origin for which a mechanism of action has not been determined. Manuscripts claiming an antiviral effect of homeopathic products or other highly diluted preparations, or which fail to clearly identify the biological ingredient or molecule responsible for the antiviral activity of an experimental therapy, will not be considered for publication. Articles describing antiseptics with broad-spectrum antimicrobial activity will not be accepted. We discourage the submission of in silico docking studies or other computer-based predictions of antiviral activity that are not supported by data from biological assays. Citations of reports that have not undergone peer review must include the note "[not peer-reviewed]."ISAR members Authors who are ISAR members are encouraged to contact ISAR after their paper has been accepted for publication in order to benefit from their published work being highlighted in ISAR postings on their social media platforms (further details on this will be given in the AVR acceptance letter). *Antiviral Research journal has started a new initiative to publish at least two thematic special issues per year, containing invited reviews in addition to the ad hoc invitations to experts in the areas within the scope of the journal.
  • Next Research

    • ISSN: 3050-4759
    Next Research is a peer-reviewed multidisciplinary journal, publishing research spanning all scientific technical and medical communities.The journal is part of the Next family, a new suite of multidisciplinary journals from Elsevier spanning all branches of science. Managed by our dedicated team of in-house Editors, Next Research offers authors speed, consistency, innovation, flexibility, and ease of submission.Next Research is an inclusive venue for scientifically accurate manuscripts that meet the ethical and scientific publishing standards. It publishes all research topics across the fields of health sciences, physical sciences, life sciences and social sciences. Next Research publishes experimental, computational, and theoretical work, in traditional formats such as Original Research Articles, Communications and Reviews, as well as novel formats and video content.The journal provides authors with rigorous peer review ensuring articles adhere to a high technical standard, with rapid decisions and a highly visible platform for scientists to share their research.We believe that all rigorous research should be shared.
  • Molecular Immunology

    • ISSN: 0161-5890
    Molecular Immunology publishes original articles, reviews and commentaries on all areas of immunology, with a particular focus on description of cellular, biochemical or genetic mechanisms underlying immunological phenomena. Studies on all model organisms, from invertebrates to humans, are suitable. Examples include, but are not restricted to:Infection, autoimmunity, transplantation, immunodeficiencies, inflammation and tumor immunologyMechanisms of induction, regulation and termination of innate and adaptive immunityIntercellula... communication, cooperation and regulationIntracellu... mechanisms of immunity (endocytosis, protein trafficking, pathogen recognition, antigen presentation, etc)Mechanisms of action of the cells and molecules of the immune systemStructural analysisDevelopment of the immune systemComparative immunology and evolution of the immune system"Omics" studies and bioinformaticsVaccin... biotechnology and therapeutic manipulation of the immune system (therapeutic antibodies, cytokines, cellular therapies, etc)Technical developmentsArticles based primarily on studies in silico must adhere to the following principles; (i) The article must report novel analytical tools, approaches and/or databases rather than using publicly available ones; or (ii) The article must include substantial experimental validation of the conclusions obtained in silico.Manuscripts related to regulatory RNA (e.g. microRNAs, lncRNAs or circRNAs) are welcome but please note: (i) they must show clear physiological relevance supported by in vivo results or clinical observations; (ii) Correlations between regulatory RNA expression with human diseases should be experimentally validated; (iii) Functions associated with the regulatory RNAs must within the scope of the journal i.e. inflammation and/or immune responses.To be acceptable for publication, studies that describe correlations between disease and genetic polymorphisms would normally be required to include novel mechanistic findings underlying the associations.Clinica... studies correlating disease and measurements of a molecule or cell type would likewise not be suitable for publication without novel mechanistic insights.Studies describing pharmacological agents are welcome if they provide significant novelty on the mechanisms of action.
  • Experimental Parasitology

    • ISSN: 0014-4894
    The main focus of Experimental Parasitology is experimental approaches to investigating different aspects of parasitology, including, but not limited to, those encompassed by molecular tools, cell biology, and immunology. The journal predominantly publishes Original Research Papers in which experimentation is used to investigate the physiological, metabolic, immunological, biochemical, nutritional, and chemotherapeutic aspects of parasites and host-parasite relationships. In addition, the journal welcomes Method Papers that describe new approaches to such investigations and Review Articles (short reviews, full reviews, and systematic reviews) that provide critical evaluation of published articles on a theme within the scope of the journal. Furthermore, the journal is open to publishing special issues or meeting reports within the themes of the journal. Please contact the editors for further information. See our Guide for Authors for further information on the different paper types accepted by Experimental Parasitology.
  • Cytokine & Growth Factor Reviews

    • ISSN: 1359-6101
    Cytokine & Growth Factor Reviews publishes thought-provoking articles (critical reviews, state-of-the-art reviews, letters to the editor, meeting reviews) devoted to important advances in the rapidly changing fields of growth factor and cytokine research. Major emphasis is placed on the multidisciplinary significance of cytokines and growth factors in areas as diverse as signal transduction, cell growth and differentiation, embryonic development, immunology, tumorigenesis and clinical medicine.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
  • Diagnostic Microbiology and Infectious Disease

    • ISSN: 0732-8893
    Diagnostic Microbiology and Infectious Disease provides up to date and extensive articles on clinical microbiology.Diagnos... Microbiology and Infectious Disease aims to publish latest developments in clinical microbiology and the diagnosis and treatment of infectious diseases. It publishes articles on studies in bacteriology, virology, mycology, parasitology, immunology related to infections, immunoserology.Submi... on new procedures, unusual cases, controversial issues, and important new literature. are particularly welcomed.The journal publishes topics including:Informed commentaries on new antibioticsRapid and cost-effective methods in the laboratoryInstructiv... case studies with emphasis on complex circumstancesInsight... editorials on important current issuesBook reviews that keep you up-to-date on recently published literatureLaboratory and clinical management of microbial diseasesEpidemiology and pathogenesis of infectionsAutomation in the diagnostic microbiology laboratoryAntibiotic susceptibility testing
  • Journal of Hospital Infection

    • ISSN: 0195-6701
    An Official Journal of the Healthcare Infection SocietyThe Journal of Hospital Infection is the editorially independent scientific publication of the Healthcare Infection Society. The aim of the Journal is to publish high quality research and information relating to infection prevention and control that is relevant to an international audience.The Journal welcomes submissions that relate to all aspects of infection prevention and control in healthcare settings. This includes submissions that:provide new insight into the epidemiology, surveillance, or prevention and control of healthcare-associate... infections and antimicrobial resistance in healthcare settings;provide new insight into cleaning, disinfection and decontamination;prov... new insight into the design of healthcare premises;describe novel aspects of outbreaks of infection;throw light on techniques for effective antimicrobial stewardship;describe novel techniques (laboratory-based or point of care) for the detection of infection or antimicrobial resistance in the healthcare setting, particularly if these can be used to facilitate infection prevention and control;improve understanding of the motivations of safe healthcare behaviour, or describe techniques for achieving behavioural and cultural change;improve understanding of the use of IT systems in infection surveillance and prevention and control.We also welcome submissions that relate to national policies or guidelines, especially where the subject matter is of international relevance.Although our readership is predominantly clinical, we are also pleased to receive basic science submissions that have clinical relevance.The Journal's open access companion title, Infection Prevention in Practice, welcomes a range of submissions providing practical information to healthcare professionals working in infection prevention and control.